Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Perrone

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Pathogens (Basel, Switzerland)|November 27, 2025
Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence StudyNicola Pugliese, Fabio Conti, Valerio Rosato, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 28, 2025
Clinical and economic outcomes of patients with cardiorenal and metabolic diseases: a real-world analysis in a single Italian Local Health UnitValentina Perrone, Domenica Daniela Ancona, Marco Gnesi, et al.
Journal of Clinical Medicine|January 8, 2023
Real-World Evidence on Disease Burden and Economic Impact of Sickle Cell Disease in ItalyLucia De Franceschi, Chiara Castiglioni, Claudia Condorelli, et al.
Heliyon|June 5, 2023
Real world study on prevalence, treatment and economic burden of myasthenia gravis in ItalyGiovanni Antonini, Francesco Habetswallner, Maurizio Inghilleri, et al.
Healthcare (Basel, Switzerland)|September 28, 2023
Characteristics and Drug Utilization of Patients with Hereditary Angioedema in Italy, a Real-World AnalysisElisa Giacomini, Melania Leogrande, Valentina Perrone, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 22, 2026
First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare CostsValentina Perrone, Vanessa Innao, Stefania Mazzoni, et al.
International Journal of Environmental Research and Public Health|March 10, 2022
Retrospective Analysis of the Pharmaco-Utilization of VEGF Inhibitors and Health Care Costs among Patients with Wet Age-Related Macular Degeneration and Other Ocular Diseases in ItalyValentina Perrone, Melania Dovizio, Chiara Veronesi, et al.
Healthcare (Basel, Switzerland)|April 23, 2022
Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical SettingValentina Perrone, Melania Dovizio, Chiara Veronesi, et al.
Therapeutics and Clinical Risk Management|August 10, 2023
Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian AnalysisFelice Alfonso Nava, Alessandra Mangia, Marco Riglietta, et al.
European Journal of Internal Medicine|October 25, 2023
Anticoagulation in atrial fibrillation. A large real-world updateMario Bo, Stefano Fumagalli, Luca Degli Esposti, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Pathogens (Basel, Switzerland)|November 27, 2025
Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence StudyNicola Pugliese, Fabio Conti, Valerio Rosato, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 28, 2025
Clinical and economic outcomes of patients with cardiorenal and metabolic diseases: a real-world analysis in a single Italian Local Health UnitValentina Perrone, Domenica Daniela Ancona, Marco Gnesi, et al.
Journal of Clinical Medicine|January 8, 2023
Real-World Evidence on Disease Burden and Economic Impact of Sickle Cell Disease in ItalyLucia De Franceschi, Chiara Castiglioni, Claudia Condorelli, et al.
Heliyon|June 5, 2023
Real world study on prevalence, treatment and economic burden of myasthenia gravis in ItalyGiovanni Antonini, Francesco Habetswallner, Maurizio Inghilleri, et al.
Healthcare (Basel, Switzerland)|September 28, 2023
Characteristics and Drug Utilization of Patients with Hereditary Angioedema in Italy, a Real-World AnalysisElisa Giacomini, Melania Leogrande, Valentina Perrone, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 22, 2026
First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare CostsValentina Perrone, Vanessa Innao, Stefania Mazzoni, et al.
International Journal of Environmental Research and Public Health|March 10, 2022
Retrospective Analysis of the Pharmaco-Utilization of VEGF Inhibitors and Health Care Costs among Patients with Wet Age-Related Macular Degeneration and Other Ocular Diseases in ItalyValentina Perrone, Melania Dovizio, Chiara Veronesi, et al.
Healthcare (Basel, Switzerland)|April 23, 2022
Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical SettingValentina Perrone, Melania Dovizio, Chiara Veronesi, et al.
Therapeutics and Clinical Risk Management|August 10, 2023
Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian AnalysisFelice Alfonso Nava, Alessandra Mangia, Marco Riglietta, et al.
European Journal of Internal Medicine|October 25, 2023
Anticoagulation in atrial fibrillation. A large real-world updateMario Bo, Stefano Fumagalli, Luca Degli Esposti, et al.
Pageof 14